Clinical Trials Directory

Trials / Unknown

UnknownNCT06064552

Screening For First Trimester's Hyperglycemia in High and Low Risk Pregnancy

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Glucose intolerance is the commonest medical disorder complicating pregnancy. Hyperglycemia increases the risk of delivering a large for gestational age newborn (LGA) and related complications such as operative delivery, birth trauma and the poor adaptation of the newborn . Maternal risks of GDM include also polyhydramnios, preeclampsia, premature delivery, prolonged labor, uterine atony, postpartum hemorrhage, infection and progression of retinopathy which are the leading global causes of maternal morbidity and mortality .Detection of women at higher risk for GDM early in pregnancy is a desirable goal because interventions such as diet, medication, and exercise may be applied earlier in pregnancy and potentially can reduce later development of GDM or its associated morbidities. Most GDM cases are diagnosed after mid-gestation following an abnormal glucose challenge test (GCT). However, about 10% of patients with GDM can be diagnosed in the first trimester.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblood sugarHigh and low risk women will undergo measuring fasting blood sugar after fasting 6-8hours with good hydration. then measuring blood sugar 1hrs and 2hrs postprandial. for patient with high results (FBS\>95mg/dl, 1hr postprandial\>126mg/dl, 2hrs postprandial \>140mg/dl) should do HA1C if \>5.6 consider it diabetic and dealing with whom positive as regard lifestyle management like diet and exercise 150 min. per week and whom not well controlled will be enrolled in pharmacological regimen as metformin. For whom measures normal will be tested by the same method at 20- 24 wks of gestation

Timeline

Start date
2023-09-24
Primary completion
2024-09-24
Completion
2024-09-24
First posted
2023-10-03
Last updated
2023-10-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06064552. Inclusion in this directory is not an endorsement.